Spyre Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Spyre Therapeutics's estimated annual revenue is currently $13M per year.
- Spyre Therapeutics's estimated revenue per employee is $155,000
- Spyre Therapeutics's total funding is $32M.
Employee Data
- Spyre Therapeutics has 84 Employees.
- Spyre Therapeutics grew their employee count by 75% last year.
Spyre Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior EA to the Chief Medical Officer | Reveal Email/Phone |
2 | Chief Intellectual Property Counsel | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Technical Officer | Reveal Email/Phone |
5 | Chief Legal Officer and Corporate Secretary | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | SVP, People | Reveal Email/Phone |
9 | VP, Corporate Controller | Reveal Email/Phone |
10 | SVP | Reveal Email/Phone |
Spyre Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Spyre Therapeutics?
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.
keywords:N/A$32M
Total Funding
84
Number of Employees
$13M
Revenue (est)
75%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.8M | 84 | 0% | $23M |
#2 | $33.6M | 84 | 22% | $20.2M |
#3 | $10.9M | 84 | -1% | $13.6M |
#4 | $15M | 84 | 2% | $173.2M |
#5 | $18.5M | 84 | 29% | N/A |